IPO GMP Explained: How Grey Market Premium, Kostak Rates & Listing Gains Work

MUMBAI, OCTOBER 12, 2026 — During trading on Monday, discussions around the unofficial Grey Market Premium (GMP) continue to be a significant, albeit unregulated, aspect of India’s primary market landscape. This guide delves into the mechanics of GMP, including Kostak rates and Subject to Sauda contracts, offering clarity on how these informal systems operate ahead of initial public offerings (IPOs).

Understanding Grey Market Premium (GMP)

The Grey Market Premium (GMP) represents the unofficial premium at which shares of an upcoming IPO are traded in the over-the-counter (OTC) market before their official listing on stock exchanges. It is an informal indicator of market sentiment and demand for an IPO, often tracked by platforms like Chittorgarh and IPOWatch. GMP is expressed as a rupee value over the upper end of the IPO price band, suggesting the potential listing price.

Unlike regulated stock market transactions, grey market dealings are entirely informal, lack legal backing, and are not monitored by SEBI or stock exchanges. This means participants bear significant counterparty risk. Despite its unofficial nature, GMP often serves as an early, albeit speculative, gauge of investor interest, influencing decisions for many retail and high net-worth individuals (HNIs) considering participation in open and upcoming IPOs.

The Mechanics of Kostak Rates

Kostak is a specific type of grey market transaction where an investor sells their entire IPO application rights for a fixed, pre-determined profit, known as the Kostak rate. This rate is agreed upon regardless of whether the investor receives an allotment or the eventual listing price of the shares.

For example, if an IPO has a Kostak rate of ₹1,500, the applicant receives ₹1,500 from the grey market operator upon applying, irrespective of allotment or listing performance. In return, if shares are allotted, the applicant transfers the shares to the grey market operator on listing day. This mechanism allows applicants to secure a fixed profit without taking on market risk, while operators bet on a higher listing premium. According to insights from Zerodha Varsity, Kostak rates are typically lower than potential listing gains but offer certainty.

Subject to Sauda: Conditional Trading

Subject to Sauda is another form of grey market transaction, but it is conditional. In this arrangement, the grey market operator agrees to purchase shares from an applicant only if the applicant receives an allotment in the IPO. The price (premium or discount) is typically decided at the time of the agreement but is contingent on successful allotment.

Unlike Kostak, where the profit is fixed and guaranteed upon application, Subject to Sauda involves higher risk for the applicant as the payout is dependent on allotment. If no shares are allotted, the agreement becomes void, and no money changes hands. This type of transaction is often preferred by operators who want to minimize their risk of paying for applications that do not result in share allotments, as highlighted by market observers on IPOWatch and InvestorZone.

Risks and Limitations of the Grey Market

While GMP provides an early indication, relying solely on it carries substantial risks:

• Lack of Regulation: The grey market is entirely unregulated. There is no legal recourse in case of disputes, non-payment, or default by counterparties.
• Counterparty Risk: Participants face the risk of the grey market operator failing to honor their commitment, especially if the IPO lists at a significant discount or premium contrary to expectations.
• Speculative Nature: GMP is driven by speculation and sentiment, not necessarily by fundamental analysis of the company. It can be highly volatile and change rapidly based on demand, subscription figures, and broader market conditions.
• No Guarantee of Listing Gains: A high GMP does not guarantee a strong listing. Market dynamics on listing day, unexpected news, or changes in investor sentiment can lead to a listing below or significantly different from the implied GMP. Livemint and Moneycontrol frequently report instances where GMP predictions diverge from actual listing performance.
• Ethical Concerns: Engaging in grey market activities can raise ethical questions due to its unofficial and unregulated nature.

Grey Market Premium: Investor Framework

Potential Benefits (as an Indicator)

• Early Sentiment Gauge: GMP can offer a preliminary look into market demand and investor excitement for an upcoming IPO.
• Unofficial Price Discovery: It provides an informal, albeit speculative, indication of where the shares might list, helping investors gauge potential short-term gains.

Key Risks & Limitations

• Unregulated Environment: Absence of regulatory oversight means no legal protection for participants.
• Counterparty Default: Significant risk of non-fulfillment of agreements by grey market operators.
• High Volatility: GMP can fluctuate wildly based on rumors, subscription updates, and general market mood, making it an unreliable long-term indicator.
• Misleading Signals: A high GMP might not translate into actual listing gains, and vice-versa, due to various market factors on listing day.

What to understand about GMP before considering it

• Verify the source and track record of any GMP data or grey market operator.
• Clearly differentiate between Kostak (fixed profit) and Subject to Sauda (conditional profit based on allotment).
• Acknowledge the complete lack of regulatory oversight and the associated counterparty risks.
• Prioritize fundamental analysis of the company’s financials, business model, and valuation over speculative GMP figures.

Frequently Asked Questions

What is Grey Market Premium (GMP) in IPOs?

Grey Market Premium (GMP) is an unofficial, unregulated premium at which shares of an upcoming IPO trade in the over-the-counter market before their official listing. It serves as a speculative indicator of market sentiment and potential listing gains, but it is not legally binding or regulated by SEBI.

What is the difference between Kostak and Subject to Sauda?

Kostak is a fixed profit paid to an IPO applicant for selling their application rights, regardless of allotment or listing performance. Subject to Sauda, however, is a conditional agreement where the payout is contingent upon the applicant successfully receiving share allotment in the IPO. Subject to Sauda carries higher risk for the applicant than Kostak.

What are the risks of relying on Grey Market Premium (GMP)?

The primary risks of relying on GMP include the complete absence of regulatory oversight, significant counterparty risk (default by the grey market operator), the highly speculative and volatile nature of GMP, and the fact that a high GMP does not guarantee actual listing gains. Investors have no legal recourse in case of disputes.

Sources referenced: Chittorgarh, IPOWatch, InvestorZone, Livemint, Zerodha Varsity

Reusing this article or its images? Credit IPO Bulletin and link to https://ipobulletin.com/ipo/grey-market-premium-unofficial-mechanics-kostak-sauda-risks-explained/gmp/. Content licence.